✦ LIBER ✦

Liver transplantation for hepatitis B: What is the best hepatitis B immune globulin/antiviral regimen?

✍ Scribed by Peter W. Angus; Scott J. Patterson

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 125 KB
Volume: 14
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21614

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B immunization after liver tra

Hepatitis B immunization after liver transplantation: What is the answer?

✍ Gregory A. Poland; John J. Poterucha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Hepatitis B virus with antigenically alt

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

✍ Ulrike Protzer-Knolle; Uta Naumann; Ralph Bartenschlager; Thomas Berg; Uwe Hopf; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

"Escape" variants of hepatitis B virus (HBV) can cause infection despite previous immunization. These viruses show alterations of the immunogenic major hydrophilic loop of the HBV small surface protein (s-protein). We studied whether HBV "escape" variants were selected in patients with graft infecti

Intramuscular hepatitis B immune globuli

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

✍ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

Mercury poisoning associated with high-d

Mercury poisoning associated with high-dose hepatitis-B immune globulin administration after liver transplantation for chronic hepatitis B

✍ Lowell, Jeffry A. ;Burgess, Sandy ;Shenoy, Surendra ;Curci, John A. ;Peters, Mar 📂 Article 📅 1996 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 309 KB

Liver transplantation for chronic hepati

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

✍ Yoshida, Eric M. ;Erb, Siegfried R. ;Partovi, Nilufar ;Scudamore, Charles H. ;Ch 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 71 KB 👁 1 views

Current protocols for prophylaxis against allograft reinfection after liver transplantation for chronic hepatitis B virus (HBV) infection include the administration of large doses of hepatitis B immune globulin (HBIG), with considerable associated economic costs. Monotherapeutic prophylaxis with lam

Protective antibody levels and dose requ

Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease

✍ Rolland C. Dickson; Norah A. Terrault; Michael Ishitani; K. Rajender Reddy; Patr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

Lamivudine combined with Hepatitis B immune globulin (HBIg) prevents post liver transplant (LT) HBV recurrence. The study was designed to assess the impact of lamivudine on hepatitis B antibody (anti-HBs) and dosage requirements of intravenous 5% HBIg (Nabi-HB) in the first 36 weeks post LT. Adults